Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study

Author： García-González Martín   Mora-Martín Manuel   López-Fernández Silvia   López-Díaz Javier   Martínez-Sellés Manuel   Romero-García José   Cordero Marco   Lara-Padrón Antonio   Marrero-Rodríguez Francisco   Mar García-Saiz M.   Aldea-Perona Ana  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.27, Iss.6, 2013-12, pp. : 573-579

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicergoline in the long term treatment of mild or moderate senile dementia. A multicenter double-blind, randomized, placebo-controlled trial

By Nicergoline Dementia Long Term Study Italian Group   Battaglia A.   Annoni K.   Pamparana F.   De Paolis C.   Bonura M.L.   Stekke W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 383-383

Elsevier

Access to resources Recommend Favorite

Rationale for and Design of the CREATIVE-AF Trial: Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effect of Irbesartan on Oxidative Stress and Adhesion Molecules in Patients with Persistent Atrial Fibrillation

By Goette Andreas  

Clinical Drug Investigation, Vol. 28, Iss. 9, 2008-01 ,pp. : 565-572

Adis International

Access to resources Recommend Favorite

Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial)

By Malerba M.   Ponticiello A.   Radaeli A.   Bensi G.   Grassi V.  

Pulmonary Pharmacology & Therapeutics, Vol. 17, Iss. 1, 2004-02 ,pp. : 27-34

Elsevier

Access to resources Recommend Favorite

Heart Rate-Lowering Efficacy and Respiratory Safety of Ivabradine in Patients with Obstructive Airway Disease: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

By Majewski Sebastian  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 3, 2012-06 ,pp. : 179-188

Adis International

Access to resources Recommend Favorite

Efficacy of Andolast in Mild to Moderate Asthma: A Randomized, Controlled, Double-Blind Multicenter Study (The Andast Trial)

By  

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3835-3843

Bentham Science Publishers

Access to resources Recommend Favorite